Cellestial Health raises £515k pre-seed round led by Zinc VC to develop astrocyte-targeting drugs for Parkinson's

Cellestial Health is developing small molecule drugs that target astrocytes in the brain, aiming to create new treatments for Parkinson’s disease and other neurodegenerative conditions with limited existing options.